Latest Advances

  • Condition: Myelofibrosis (MF)
  • Journal: Hematology/oncology clinics of North America
  • Treatment Used: Stem Cell Therapy
  • Number of Patients: 0
  • Published —
This article discusses the use of stem cell therapy in patients with myelofibrosis (MF).
  • Condition: Myelofibrosis
  • Journal: American journal of hematology
  • Treatment Used: Splenectomy before Allogeneic Hematopoietic Cell Transplantation
  • Number of Patients: 530
  • Published —
The study researched the outcomes of splenectomy before allogeneic hematopoietic cell transplantation for patients with myelofibrosis.
  • Condition: Polycythemia Vera Or Myelofibrosis
  • Journal: Haematologica
  • Treatment Used: Ruxolitinib and Interferon-?2 Combination Therapy
  • Number of Patients: 32
  • Published —
In this study, researchers evaluated the outcomes of using ruxolitinib and interferon-?2 combination therapy for the treatment of polycythemia vera or myelofibrosis
  • Condition: Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis
  • Journal: Internal medicine (Tokyo, Japan)
  • Treatment Used: Allogeneic Hematopoietic Stem Cell Transplantation
  • Number of Patients: 38
  • Published —
In this study, researchers evaluated the outcomes of undergoing allogeneic hematopoietic stem cell transplantation for the treatment of secondary myelofibrosis due to essential thrombocythemia and polycythemia vera.
  • Condition: Myelofibrosis (MF)
  • Journal: Blood advances
  • Treatment Used: Combination Sonidegib and Ruxolitinib
  • Number of Patients: 50
  • Published —
This study assessed sonidegib and ruxolitinib combination in JAK inhibitor-naive patients with myelofibrosis (MF).
  • Condition: Primary Myelofibrosis with COVID-19
  • Journal: European journal of haematology
  • Treatment Used: Ruxolitinib
  • Number of Patients: 1
  • Published —
This case report describes a patient with primary myelofibrosis that also has a COVID-19 infection who was treated using ruxolitinib.
  • Condition: Myelofibrosis
  • Journal: Blood reviews
  • Treatment Used: Targeted and Combined Therapies and Allogenic Stem Cell Transplant
  • Number of Patients: 0
  • Published —
This article discusses both standard and novel therapies for the treatment of patients with myelofibrosis.
  • Condition: Acute Kidney Injury caused by TAFRO Syndrome
  • Journal: Kidney & blood pressure research
  • Treatment Used: Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide
  • Number of Patients: 1
  • Published —
The study researched the outcomes of a case of acute kidney injury caused by TAFRO syndrome.
  • Condition: Myelofibrosis
  • Journal: Clinical lymphoma, myeloma & leukemia
  • Treatment Used: Splenectomy
  • Number of Patients: 0
  • Published —
This article describes the effectiveness, indications, and complications of splenectomy for the treatment of patients with myelofibrosis (MF).
  • Condition: Essential Thrombocythemia
  • Journal: European journal of haematology
  • Treatment Used: Anagrelide
  • Number of Patients: 150
  • Published —
In this study, researchers evaluated the long-term, real world outcomes of using anagrelide for the treatment of essential thrombocythemia.
Showing 1-12 of 59